Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Summary
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.7...
Description
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.7...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source